Article info

Download PDFPDF

Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser

Authors

  1. Correspondence to Dr Paul Taylor, Institute of Health Informatics, University College London, London WC1E 6BT, UK; p.taylor{at}ucl.ac.uk
View Full Text

Citation

Gale R, Pikoula M, Lee AY on behalf of UK EMR Users Group, et al
Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser

Publication history

  • Received January 10, 2020
  • Revised April 27, 2020
  • Accepted May 14, 2020
  • First published June 12, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.